Contrasting Elevance Health (ELV) & The Competition

Elevance Health (NYSE:ELV) is one of 233 public companies in the “Healthcare Providers & Services” industry, but how does it contrast to its peers? We will compare Elevance Health to related companies based on the strength of its analyst recommendations, profitability, earnings, dividends, institutional ownership, valuation and risk.

Earnings & Valuation

This table compares Elevance Health and its peers gross revenue, earnings per share (EPS) and valuation.

	Gross Revenue	Net Income	Price/Earnings Ratio
Elevance Health	$199.12 billion	$5.66 billion	17.99
Elevance Health Competitors	$21.12 billion	$301.67 million	-1.67

Elevance Health has higher revenue and earnings than its peers. Elevance Health is trading at a higher price-to-earnings ratio than its peers, indicating that it is currently more expensive than other companies in its industry.

Volatility and Risk

Elevance Health has a beta of 0.63, indicating that its stock price is 37% less volatile than the S&P 500. Comparatively, Elevance Health’s peers have a beta of 0.98, indicating that their average stock price is 2% less volatile than the S&P 500.

Insider and Institutional Ownership

89.2% of Elevance Health shares are held by institutional investors. Comparatively, 56.7% of shares of all “Healthcare Providers & Services” companies are held by institutional investors. 0.3% of Elevance Health shares are held by insiders. Comparatively, 15.0% of shares of all “Healthcare Providers & Services” companies are held by insiders. Strong institutional ownership is an indication that large money managers, endowments and hedge funds believe a company will outperform the market over the long term.

Profitability

This table compares Elevance Health and its peers’ net margins, return on equity and return on assets.

	Net Margins	Return on Equity	Return on Assets
Elevance Health	2.55%	14.97%	5.31%
Elevance Health Competitors	-8.06%	-136.95%	-1.64%

Dividends

Elevance Health pays an annual dividend of $6.88 per share and has a dividend yield of 1.6%. Elevance Health pays out 29.3% of its earnings in the form of a dividend. As a group, “Healthcare Providers & Services” companies pay a dividend yield of 1.4% and pay out 24.7% of their earnings in the form of a dividend. Elevance Health has increased its dividend for 14 consecutive years.

Analyst Recommendations

This is a summary of current ratings and target prices for Elevance Health and its peers, as provided by MarketBeat.com.

	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
Elevance Health	0	7	15	0	2.68
Elevance Health Competitors	1873	7748	13377	829	2.55

Elevance Health currently has a consensus price target of $456.48, suggesting a potential upside of 8.20%. As a group, “Healthcare Providers & Services” companies have a potential upside of 14.73%. Given Elevance Health’s peers higher probable upside, analysts clearly believe Elevance Health has less favorable growth aspects than its peers.

Summary

Elevance Health beats its peers on 10 of the 15 factors compared.

About Elevance Health

Elevance Health, Inc. is a U.S. health benefits and services company. Formerly known as Anthem, Inc., it adopted the Elevance Health name in 2022 while retaining the Anthem brand for many of its health plans. The company offers medical, pharmacy, dental, vision and behavioral health coverage, including plans for individuals and employers as well as programs serving Medicare and Medicaid members. Its services also include care management, pharmacy benefit services and other health-related capabilities through its Carelon business.